CD30, Human (Iratumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD30, Human (Iratumumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD30, Human (Iratumumab biosimilar)
CloneIratumumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIP, IF, FuncS, FCM, Neut, ELISA, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD30 Recombinant Antibody (Iratumumab). Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease. This drug was developed by Medarex, which was later acquired by Bristol-Myers Squibb.
Immunogenn/a
Other NamesAnti-CD30 Recombinant Antibody, Research Grade Iratumumab, Anti-Human CD30 Recombinant Antibody(Iratumumab), MDX-060, Antibody Drug Analogues, Monoclonal Antibody, YR1162, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 640735-09-7
Catalog #YR1162
Priceplease inquire
Order / More InfoCD30, Human (Iratumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.